With research and development costs for many drugs reaching well into the billions, pharmaceutical companies want more than ever to determine whether their drugs already at market have… read more.
Substance abuse assessments needed before drugs are prescribed, researchers say. Teens prescribed anti-anxiety or sleep medications may be up to 12 times more likely to abuse those drugs… read more.
by Bruce Sylvester – Microvascular complications of diabetes that can lead to blindness and amputations might be reduced by statin therapy, researchers reported on Sept.9, 2014 in The Lancet… read more.
by Bruce Sylvester – Viagra® (sildenafil citrate) might be useful in safely treating heart disease, researchers reported on Oct. 19, 2014 in l BMC Medicine. The study suggests that… read more.
by Bruce Sylvester – New “real world” data suggests that the efficacy of Remsima® (infliximab), a biosimilar monoclonal antibody (mAb) anti-TNF-alpha agent approved by the European Commission, is… read more.
Professor David P. Finn PhD BSc, Professor of Pharmacology and Therapeutics, Leader: Galway Neuroscience Centre, Co-Director: Centre for Pain Research, Pharmacology & Therapeutics, School of Medicine, National University… read more.
Professor David P. Finn PhD BSc, Professor of Pharmacology and Therapeutics, Leader: Galway Neuroscience Centre, Co-Director: Centre for Pain Research, Pharmacology & Therapeutics, School of Medicine, National University… read more.
Professor David P. Finn PhD BSc, Professor of Pharmacology and Therapeutics, Leader: Galway Neuroscience Centre, Co-Director: Centre for Pain Research, Pharmacology & Therapeutics, School of Medicine, National University… read more.
Professor David P. Finn PhD BSc, Professor of Pharmacology and Therapeutics, Leader: Galway Neuroscience Centre, Co-Director: Centre for Pain Research, Pharmacology & Therapeutics, School of Medicine, National University… read more.
by Gary Finnegan – The EMA’s influential Committee for Medicinal Products for Human Use (CHMP) approved six new medicines at its June meeting, including a breakthrough hepatitis C… read more.
by Gary Finnegan – The European Medicines Agency (EMA) is reviewing the cardiovascular risks of systemic ibuprofen medicines. The focus is expected to be on tablets taken by… read more.
by Gary Finnegan – The EU medicines regulator has rejigged its plan on how clinical trial data will be shared with health professionals, after intense lobbying by doctors,… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
